Lumicell CEO and leadership

Kevin Hershberger joined as Chief Financial Officer in January 2015. Before joining ReWalk, he served as Vice President, Controller and Chief Accounting Officer at NxStage Medical Inc., a Nasdaq-listed manufacturer of innovative dialysis products. During his over six-year tenure, Mr. Hershberger led the financial operations, improved gross margins, participated in fund-raising activities, and established a joint venture manufacturing operation in Germany. Prior to NxStage, Mr. Hershberger worked for nearly ten years in positions of increasing responsibility at Boston Scientific Corporation (NYSE: BSX), a global developer, manufacturer and distributor of less invasive medical devices, ultimately serving as Controller/Director Finance—Urology & Gynecology. Mr. Hershberger began his career as an accountant at the USG Corporation, a global manufacturer and distributor of building materials. Mr. Hershberger is a graduate of West Virginia University with a Bachelors of Science degree in accounting, and a Company Commander in the U.S. Army Reserves.

W. David Lee is a Chief Executive Officer at Precision Healing and Chief Scientific Officer at Lumicell and is based in Greater Boston Area. He has worked as Co-founded & Founding CEO at T2 BIOSYSTEMS, INC. and Senior Vice President & Managing Director at Arthur D Little. W. studied at Massachusetts Institute of Technology (MIT) and Harvard Business School.

Felix Geissler is a Chief Medical Officer at Lumicell and is based in Cambridge, Massachusetts. He has worked as Assistant Professor, Department of Surgery at University of Wisconsin-Madison and Associate Director of Medical Affairs, Immunoscience at Bristol Myers Squibb.

W. David Lee is a Chief Executive Officer at Precision Healing and Chief Scientific Officer at Lumicell and is based in Greater Boston Area. He has worked as Co-founded & Founding CEO at T2 BIOSYSTEMS, INC. and Senior Vice President & Managing Director at Arthur D Little. W. studied at Massachusetts Institute of Technology (MIT) and Harvard Business School.

Kevin Hershberger joined as Chief Financial Officer in January 2015. Before joining ReWalk, he served as Vice President, Controller and Chief Accounting Officer at NxStage Medical Inc., a Nasdaq-listed manufacturer of innovative dialysis products. During his over six-year tenure, Mr. Hershberger led the financial operations, improved gross margins, participated in fund-raising activities, and established a joint venture manufacturing operation in Germany. Prior to NxStage, Mr. Hershberger worked for nearly ten years in positions of increasing responsibility at Boston Scientific Corporation (NYSE: BSX), a global developer, manufacturer and distributor of less invasive medical devices, ultimately serving as Controller/Director Finance—Urology & Gynecology. Mr. Hershberger began his career as an accountant at the USG Corporation, a global manufacturer and distributor of building materials. Mr. Hershberger is a graduate of West Virginia University with a Bachelors of Science degree in accounting, and a Company Commander in the U.S. Army Reserves.

W. David Lee is a Chief Executive Officer at Precision Healing and Chief Scientific Officer at Lumicell and is based in Greater Boston Area. He has worked as Co-founded & Founding CEO at T2 BIOSYSTEMS, INC. and Senior Vice President & Managing Director at Arthur D Little. W. studied at Massachusetts Institute of Technology (MIT) and Harvard Business School.